Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials
Background. The combination of several diagnostic methods is used to predict treatment outcomes, assess overall survival, and increase the positive predictive value of detecting malignant lung and bronchial tumors. Aim. To evaluate the diagnostic value of the CLIA-СА-62 chemiluminescence immunoas...
Main Authors: | Janneta R. Tcherkassova, Anna I. Prostyakova, Sergei A. Tsurkan, Nikolai V. Suganov, Alexander M. Boroda, Angelina V. Zhilenkova, Juliya N. Pirogova, Zaiana D. Sangadzhieva, Aleksandr S. Rusanov, Aleksandr A. Rozhkov, Anastasia S. Fatyanova, Natalia M. Nikitina, Nikolay N. Bagmet, Marina I. Sekacheva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2023-05-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/241215/pdf |
Similar Items
-
Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
by: Marina Sekacheva, et al.
Published: (2023-05-01) -
Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results
by: Janneta R. Tcherkassova, et al.
Published: (2023-06-01) -
A PILOT CLINICAL TRIAL TO MONITOR RESPONSE TO CHEMOTHERAPY USING THE CA-62 MARKER OF EPITHELIAL CARCINOMAS
by: G. G. Khakimova, et al.
Published: (2019-11-01) -
Hyperprolactinaemia and its Comparision with Hypothyroidism in Primary Infertile Women
by: Sunita Turankar, et al.
Published: (2013-05-01) -
Improving the diagnosis of active tuberculosis: a novel approach using magnetic particle-based chemiluminescence LAM assay
by: Yan Li, et al.
Published: (2024-02-01)